Oral, Zebedee Kemuel T.
HRN: 21-67-84 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/03/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/03/2025
11/10/2025
IV
500mg
Q6
BFC; PCAP B
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes